Literature DB >> 25680740

Predictors of kidney disease in a cohort of pediatric patients with lupus.

S D Sule1, D G Moodalbail2, J Burnham3, B Fivush4, S L Furth5.   

Abstract

INTRODUCTION: Children with systemic lupus erythematosus (SLE) have an increased prevalence of kidney disease compared to their adult counterparts. Our goal was to identify potential clinical and laboratory predictors of renal disease.
METHODS: We performed a cohort study of incident and prevalent patients with SLE aged ≤19 years. Retrospective data from initial presentation until study enrollment was also collected. Laboratory and clinic data were recorded from each clinic visit including disease activity indices, autoantibodies, urinalyses, blood counts, and metabolic profile. Kidney disease was defined as the presence of abnormal renal biopsy or by American College of Rheumatology case definition for lupus nephritis. Logistic regression analyses were used to determine the association between clinical and laboratory data with kidney disease in those who had renal involvement within 30 days of SLE diagnosis. We also performed a time to event analysis to identify antecedents of renal disease.
RESULTS: Forty-seven children and adolescents with SLE were followed in the cohort, 91% female and 68% black. All of the males in the cohort developed renal disease, and all within one month of the diagnosis of SLE. In logistic regression, low serum albumin (odds ratio (OR): 4.8, 95% CI: 1.9-12.5) and positive dsDNA antibodies (OR: 3.2, 95% CI: 1.7-5.9) were associated with kidney disease. In longitudinal analyses, isolated sterile pyuria (hazard ratio (HR): 3, 95% CI: 1.1-6.4) and low serum albumin (HR: 3.4, 95% CI: 1.7-6.9) were predictors of future kidney disease. The presence of antibodies against Ro were protective against renal disease (HR: 0.2, 95% CI: 0.05-0.5).
CONCLUSION: We identified variables associated with kidney disease, both at initial diagnosis of SLE and in longitudinal follow-up in a cohort of children with SLE. The recognition of these abnormal laboratory values may help clinicians identify patients at risk for kidney disease before its onset thus preventing long-term complications.
© The Author(s) 2015.

Entities:  

Keywords:  Renal lupus; nephritis; systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 25680740      PMCID: PMC4466076          DOI: 10.1177/0961203315570162

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  38 in total

1.  A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.

Authors:  A Ho; S G Barr; L S Magder; M Petri
Journal:  Arthritis Rheum       Date:  2001-10

2.  Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.

Authors:  A Ho; L S Magder; S G Barr; M Petri
Journal:  Arthritis Rheum       Date:  2001-10

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis.

Authors:  Tamar Rubinstein; Milena Pitashny; Benjamin Levine; Noa Schwartz; Julie Schwartzman; Elena Weinstein; Jose M Pego-Reigosa; Tim Y-T Lu; David Isenberg; Anisur Rahman; Chaim Putterman
Journal:  Rheumatology (Oxford)       Date:  2010-02-09       Impact factor: 7.580

5.  Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus.

Authors:  J W Chien; C Y Lin; L Y Yang
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2001-05

6.  Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Authors:  Brad H Rovin; Huijuan Song; Dan J Birmingham; Lee A Hebert; Chack Yung Yu; Haikady N Nagaraja
Journal:  J Am Soc Nephrol       Date:  2004-12-15       Impact factor: 10.121

Review 7.  Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus.

Authors:  J B Harley; R H Scofield; M Reichlin
Journal:  Rheum Dis Clin North Am       Date:  1992-05       Impact factor: 2.670

8.  Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy.

Authors:  S-J Moon; H S Park; S-K Kwok; J H Ju; B S Choi; K-S Park; J-K Min; H-Y Kim; S-H Park
Journal:  Lupus       Date:  2013-02-19       Impact factor: 2.911

9.  Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.

Authors:  Michiko Suzuki; Kristina M Wiers; Marisa S Klein-Gitelman; Kathleen A Haines; Judyann Olson; Karen B Onel; Kathleen O'Neil; Murray H Passo; Nora G Singer; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I Brunner
Journal:  Pediatr Nephrol       Date:  2008-01-17       Impact factor: 3.714

10.  Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.

Authors:  Claas H Hinze; Michiko Suzuki; Marisa Klein-Gitelman; Murray H Passo; Judyann Olson; Nora G Singer; Kathleen A Haines; Karen Onel; Kathleen O'Neil; Earl D Silverman; Lori Tucker; Jun Ying; Prasad Devarajan; Hermine I Brunner
Journal:  Arthritis Rheum       Date:  2009-09
View more
  6 in total

Review 1.  Advances in the care of children with lupus nephritis.

Authors:  Scott E Wenderfer; Natasha M Ruth; Hermine I Brunner
Journal:  Pediatr Res       Date:  2016-11-17       Impact factor: 3.756

Review 2.  Biomarkers for kidney involvement in pediatric lupus.

Authors:  Beatrice Goilav; Chaim Putterman; Tamar B Rubinstein
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

3.  Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis.

Authors:  Pornpimol Rianthavorn; Athitaya Buddhasri
Journal:  Pediatr Nephrol       Date:  2015-06-09       Impact factor: 3.714

4.  Autoantibody cluster analysis in juvenile lupus nephritis.

Authors:  Matthew A Sherman; Amali Gunawardana; Janine P Amirault; Asha Moudgil; James E Bost; Sangeeta Sule; Hemalatha Srinivasalu
Journal:  Clin Rheumatol       Date:  2022-03-28       Impact factor: 3.650

5.  Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus.

Authors:  Najla Aljaberi; Scott E Wenderfer; Arjun Mathur; Tingting Qiu; Steffy Jose; Angela Merritt; James Rose; Prasad Devarajan; Bin Huang; Hermine Brunner
Journal:  Lupus Sci Med       Date:  2022-05

6.  Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis.

Authors:  Oh Chan Kwon; Jung Hwan Park; Hyeong-Cheon Park; Seung Min Jung; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park; Min-Chan Park
Journal:  Arthritis Res Ther       Date:  2020-06-09       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.